nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS1—kidney cancer	0.447	0.636	CbGaD
Oxaprozin—PTGS2—kidney cancer	0.256	0.364	CbGaD
Oxaprozin—CYP2C9—Capecitabine—kidney cancer	0.0145	0.458	CbGbCtD
Oxaprozin—CYP2C9—Paclitaxel—kidney cancer	0.00907	0.287	CbGbCtD
Oxaprozin—CYP2C9—Sorafenib—kidney cancer	0.00806	0.255	CbGbCtD
Oxaprozin—Fenbufen—PTGS1—kidney cancer	0.000611	0.207	CrCbGaD
Oxaprozin—Phenylbutazone—PTGS1—kidney cancer	0.000351	0.119	CrCbGaD
Oxaprozin—Fenbufen—PTGS2—kidney cancer	0.000349	0.118	CrCbGaD
Oxaprozin—Warfarin—CYP1A1—kidney cancer	0.000307	0.104	CrCbGaD
Oxaprozin—Flurbiprofen—PTGS1—kidney cancer	0.000286	0.0971	CrCbGaD
Oxaprozin—Phenylbutazone—PTGS2—kidney cancer	0.000201	0.068	CrCbGaD
Oxaprozin—Diphenhydramine—PTGS1—kidney cancer	0.000191	0.0648	CrCbGaD
Oxaprozin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000164	0.00071	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—kidney cancer	0.000164	0.0555	CrCbGaD
Oxaprozin—Tremor—Paclitaxel—kidney cancer	0.000164	0.000707	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000163	0.000703	CcSEcCtD
Oxaprozin—Insomnia—Vincristine—kidney cancer	0.000162	0.000701	CcSEcCtD
Oxaprozin—Anorexia—Gemcitabine—kidney cancer	0.000162	0.000701	CcSEcCtD
Oxaprozin—Vomiting—Vinblastine—kidney cancer	0.000162	0.000701	CcSEcCtD
Oxaprozin—Dizziness—Erlotinib—kidney cancer	0.000162	0.0007	CcSEcCtD
Oxaprozin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000162	0.0007	CcSEcCtD
Oxaprozin—Vomiting—Everolimus—kidney cancer	0.000162	0.000698	CcSEcCtD
Oxaprozin—Anaemia—Paclitaxel—kidney cancer	0.000161	0.000698	CcSEcCtD
Oxaprozin—Renal impairment—Doxorubicin—kidney cancer	0.000161	0.000697	CcSEcCtD
Oxaprozin—Paraesthesia—Vincristine—kidney cancer	0.000161	0.000696	CcSEcCtD
Oxaprozin—Rash—Everolimus—kidney cancer	0.00016	0.000692	CcSEcCtD
Oxaprozin—Dermatitis—Everolimus—kidney cancer	0.00016	0.000692	CcSEcCtD
Oxaprozin—Headache—Vinblastine—kidney cancer	0.00016	0.00069	CcSEcCtD
Oxaprozin—Angioedema—Paclitaxel—kidney cancer	0.00016	0.00069	CcSEcCtD
Oxaprozin—Propafenone—ABCB1—kidney cancer	0.000159	0.0541	CrCbGaD
Oxaprozin—Purpura—Doxorubicin—kidney cancer	0.000159	0.000688	CcSEcCtD
Oxaprozin—Headache—Everolimus—kidney cancer	0.000159	0.000688	CcSEcCtD
Oxaprozin—Hypotension—Gemcitabine—kidney cancer	0.000159	0.000687	CcSEcCtD
Oxaprozin—Abdominal pain—Dactinomycin—kidney cancer	0.000159	0.000686	CcSEcCtD
Oxaprozin—Body temperature increased—Dactinomycin—kidney cancer	0.000159	0.000686	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000159	0.000685	CcSEcCtD
Oxaprozin—Asthenia—Sorafenib—kidney cancer	0.000158	0.000684	CcSEcCtD
Oxaprozin—Malaise—Paclitaxel—kidney cancer	0.000158	0.000681	CcSEcCtD
Oxaprozin—Vertigo—Paclitaxel—kidney cancer	0.000157	0.000678	CcSEcCtD
Oxaprozin—Syncope—Paclitaxel—kidney cancer	0.000157	0.000677	CcSEcCtD
Oxaprozin—Lethargy—Doxorubicin—kidney cancer	0.000157	0.000677	CcSEcCtD
Oxaprozin—Leukopenia—Paclitaxel—kidney cancer	0.000156	0.000676	CcSEcCtD
Oxaprozin—Decreased appetite—Vincristine—kidney cancer	0.000156	0.000674	CcSEcCtD
Oxaprozin—Pruritus—Sorafenib—kidney cancer	0.000156	0.000674	CcSEcCtD
Oxaprozin—Vomiting—Erlotinib—kidney cancer	0.000156	0.000673	CcSEcCtD
Oxaprozin—Erythema multiforme—Capecitabine—kidney cancer	0.000156	0.000673	CcSEcCtD
Oxaprozin—Rash—Erlotinib—kidney cancer	0.000155	0.000668	CcSEcCtD
Oxaprozin—Dermatitis—Erlotinib—kidney cancer	0.000154	0.000667	CcSEcCtD
Oxaprozin—Palpitations—Paclitaxel—kidney cancer	0.000154	0.000667	CcSEcCtD
Oxaprozin—Insomnia—Gemcitabine—kidney cancer	0.000154	0.000665	CcSEcCtD
Oxaprozin—Headache—Erlotinib—kidney cancer	0.000154	0.000664	CcSEcCtD
Oxaprozin—Tinnitus—Capecitabine—kidney cancer	0.000154	0.000663	CcSEcCtD
Oxaprozin—Loss of consciousness—Paclitaxel—kidney cancer	0.000154	0.000663	CcSEcCtD
Oxaprozin—Constipation—Vincristine—kidney cancer	0.000154	0.000663	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000153	0.000663	CcSEcCtD
Oxaprozin—Paraesthesia—Gemcitabine—kidney cancer	0.000153	0.000661	CcSEcCtD
Oxaprozin—Asthenia—Sunitinib—kidney cancer	0.000152	0.000658	CcSEcCtD
Oxaprozin—Dyspnoea—Gemcitabine—kidney cancer	0.000152	0.000656	CcSEcCtD
Oxaprozin—Nausea—Vinblastine—kidney cancer	0.000152	0.000655	CcSEcCtD
Oxaprozin—Somnolence—Gemcitabine—kidney cancer	0.000151	0.000654	CcSEcCtD
Oxaprozin—Convulsion—Paclitaxel—kidney cancer	0.000151	0.000654	CcSEcCtD
Oxaprozin—Nausea—Everolimus—kidney cancer	0.000151	0.000652	CcSEcCtD
Oxaprozin—Diarrhoea—Sorafenib—kidney cancer	0.000151	0.000652	CcSEcCtD
Oxaprozin—Hypertension—Paclitaxel—kidney cancer	0.000151	0.000652	CcSEcCtD
Oxaprozin—Pruritus—Sunitinib—kidney cancer	0.00015	0.000649	CcSEcCtD
Oxaprozin—Anxiety—Paclitaxel—kidney cancer	0.000148	0.00064	CcSEcCtD
Oxaprozin—Decreased appetite—Gemcitabine—kidney cancer	0.000148	0.00064	CcSEcCtD
Oxaprozin—Arrhythmia—Capecitabine—kidney cancer	0.000147	0.000636	CcSEcCtD
Oxaprozin—Discomfort—Paclitaxel—kidney cancer	0.000147	0.000635	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Vincristine—kidney cancer	0.000147	0.000634	CcSEcCtD
Oxaprozin—Dizziness—Sorafenib—kidney cancer	0.000146	0.00063	CcSEcCtD
Oxaprozin—Constipation—Gemcitabine—kidney cancer	0.000146	0.000629	CcSEcCtD
Oxaprozin—Nausea—Erlotinib—kidney cancer	0.000146	0.000629	CcSEcCtD
Oxaprozin—Alopecia—Capecitabine—kidney cancer	0.000146	0.000629	CcSEcCtD
Oxaprozin—Dry mouth—Paclitaxel—kidney cancer	0.000145	0.000628	CcSEcCtD
Oxaprozin—Diarrhoea—Sunitinib—kidney cancer	0.000145	0.000627	CcSEcCtD
Oxaprozin—Asthenia—Dactinomycin—kidney cancer	0.000144	0.000623	CcSEcCtD
Oxaprozin—Confusional state—Paclitaxel—kidney cancer	0.000144	0.000621	CcSEcCtD
Oxaprozin—Oedema—Paclitaxel—kidney cancer	0.000143	0.000616	CcSEcCtD
Oxaprozin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000143	0.000616	CcSEcCtD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—kidney cancer	0.000142	0.00461	CbGpPWpGaD
Oxaprozin—Abdominal pain—Vincristine—kidney cancer	0.000142	0.000613	CcSEcCtD
Oxaprozin—Body temperature increased—Vincristine—kidney cancer	0.000142	0.000613	CcSEcCtD
Oxaprozin—Infection—Paclitaxel—kidney cancer	0.000142	0.000612	CcSEcCtD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SOD2—kidney cancer	0.000142	0.00459	CbGpPWpGaD
Oxaprozin—Flatulence—Capecitabine—kidney cancer	0.000141	0.00061	CcSEcCtD
Oxaprozin—Dysgeusia—Capecitabine—kidney cancer	0.00014	0.000607	CcSEcCtD
Oxaprozin—Dizziness—Sunitinib—kidney cancer	0.00014	0.000606	CcSEcCtD
Oxaprozin—Feeling abnormal—Gemcitabine—kidney cancer	0.00014	0.000606	CcSEcCtD
Oxaprozin—Shock—Paclitaxel—kidney cancer	0.00014	0.000606	CcSEcCtD
Oxaprozin—Vomiting—Sorafenib—kidney cancer	0.00014	0.000606	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—kidney cancer	0.00014	0.000606	CcSEcCtD
Oxaprozin—Thrombocytopenia—Paclitaxel—kidney cancer	0.00014	0.000603	CcSEcCtD
Oxaprozin—Tachycardia—Paclitaxel—kidney cancer	0.000139	0.000601	CcSEcCtD
Oxaprozin—Rash—Sorafenib—kidney cancer	0.000139	0.000601	CcSEcCtD
Oxaprozin—Dermatitis—Sorafenib—kidney cancer	0.000139	0.0006	CcSEcCtD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—kidney cancer	0.000138	0.00449	CbGpPWpGaD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000138	0.000597	CcSEcCtD
Oxaprozin—Headache—Sorafenib—kidney cancer	0.000138	0.000597	CcSEcCtD
Oxaprozin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000138	0.000595	CcSEcCtD
Oxaprozin—Diarrhoea—Dactinomycin—kidney cancer	0.000137	0.000594	CcSEcCtD
Oxaprozin—Anorexia—Paclitaxel—kidney cancer	0.000136	0.000587	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—kidney cancer	0.000136	0.000587	CcSEcCtD
Oxaprozin—Vision blurred—Capecitabine—kidney cancer	0.000135	0.000584	CcSEcCtD
Oxaprozin—Vomiting—Sunitinib—kidney cancer	0.000135	0.000583	CcSEcCtD
Oxaprozin—Body temperature increased—Gemcitabine—kidney cancer	0.000135	0.000582	CcSEcCtD
Oxaprozin—Tremor—Capecitabine—kidney cancer	0.000134	0.00058	CcSEcCtD
Oxaprozin—Rash—Sunitinib—kidney cancer	0.000134	0.000578	CcSEcCtD
Oxaprozin—Dermatitis—Sunitinib—kidney cancer	0.000134	0.000578	CcSEcCtD
Oxaprozin—Hypotension—Paclitaxel—kidney cancer	0.000133	0.000576	CcSEcCtD
Oxaprozin—Ill-defined disorder—Capecitabine—kidney cancer	0.000133	0.000575	CcSEcCtD
Oxaprozin—Headache—Sunitinib—kidney cancer	0.000133	0.000574	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—kidney cancer	0.000133	0.000573	CcSEcCtD
Oxaprozin—Anaemia—Capecitabine—kidney cancer	0.000133	0.000572	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—kidney cancer	0.000131	0.000567	CcSEcCtD
Oxaprozin—Nausea—Sorafenib—kidney cancer	0.000131	0.000566	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—kidney cancer	0.00013	0.000562	CcSEcCtD
Oxaprozin—PTGS1—Biological oxidations—GSTT1—kidney cancer	0.000129	0.0042	CbGpPWpGaD
Oxaprozin—Malaise—Capecitabine—kidney cancer	0.000129	0.000559	CcSEcCtD
Oxaprozin—Insomnia—Paclitaxel—kidney cancer	0.000129	0.000557	CcSEcCtD
Oxaprozin—Vertigo—Capecitabine—kidney cancer	0.000129	0.000556	CcSEcCtD
Oxaprozin—Asthenia—Vincristine—kidney cancer	0.000129	0.000556	CcSEcCtD
Oxaprozin—Syncope—Capecitabine—kidney cancer	0.000129	0.000555	CcSEcCtD
Oxaprozin—Leukopenia—Capecitabine—kidney cancer	0.000128	0.000554	CcSEcCtD
Oxaprozin—Paraesthesia—Paclitaxel—kidney cancer	0.000128	0.000553	CcSEcCtD
Oxaprozin—Vomiting—Dactinomycin—kidney cancer	0.000128	0.000552	CcSEcCtD
Oxaprozin—PTGS2—Spinal Cord Injury—ANXA1—kidney cancer	0.000128	0.00414	CbGpPWpGaD
Oxaprozin—Dyspnoea—Paclitaxel—kidney cancer	0.000127	0.000549	CcSEcCtD
Oxaprozin—Somnolence—Paclitaxel—kidney cancer	0.000127	0.000548	CcSEcCtD
Oxaprozin—Palpitations—Capecitabine—kidney cancer	0.000127	0.000547	CcSEcCtD
Oxaprozin—Rash—Dactinomycin—kidney cancer	0.000127	0.000547	CcSEcCtD
Oxaprozin—Nausea—Sunitinib—kidney cancer	0.000126	0.000545	CcSEcCtD
Oxaprozin—Loss of consciousness—Capecitabine—kidney cancer	0.000126	0.000544	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—kidney cancer	0.000126	0.000544	CcSEcCtD
Oxaprozin—Dyspepsia—Paclitaxel—kidney cancer	0.000126	0.000542	CcSEcCtD
Oxaprozin—PTGS1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000125	0.00405	CbGpPWpGaD
Oxaprozin—Dysuria—Doxorubicin—kidney cancer	0.000124	0.000536	CcSEcCtD
Oxaprozin—Decreased appetite—Paclitaxel—kidney cancer	0.000124	0.000535	CcSEcCtD
Oxaprozin—Hypertension—Capecitabine—kidney cancer	0.000124	0.000535	CcSEcCtD
Oxaprozin—Diarrhoea—Vincristine—kidney cancer	0.000123	0.000531	CcSEcCtD
Oxaprozin—Asthenia—Gemcitabine—kidney cancer	0.000122	0.000528	CcSEcCtD
Oxaprozin—Carbamazepine—ABCB1—kidney cancer	0.000122	0.0413	CrCbGaD
Oxaprozin—Constipation—Paclitaxel—kidney cancer	0.000122	0.000527	CcSEcCtD
Oxaprozin—Anxiety—Capecitabine—kidney cancer	0.000122	0.000525	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000121	0.000523	CcSEcCtD
Oxaprozin—Discomfort—Capecitabine—kidney cancer	0.000121	0.000521	CcSEcCtD
Oxaprozin—Pruritus—Gemcitabine—kidney cancer	0.00012	0.000521	CcSEcCtD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00012	0.0039	CbGpPWpGaD
Oxaprozin—Hyperglycaemia—Doxorubicin—kidney cancer	0.00012	0.000517	CcSEcCtD
Oxaprozin—Dry mouth—Capecitabine—kidney cancer	0.000119	0.000516	CcSEcCtD
Oxaprozin—Nausea—Dactinomycin—kidney cancer	0.000119	0.000516	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—kidney cancer	0.000119	0.000514	CcSEcCtD
Oxaprozin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—kidney cancer	0.000119	0.00386	CbGpPWpGaD
Oxaprozin—Dizziness—Vincristine—kidney cancer	0.000119	0.000513	CcSEcCtD
Oxaprozin—Phenytoin—ABCB1—kidney cancer	0.000119	0.0402	CrCbGaD
Oxaprozin—Drowsiness—Doxorubicin—kidney cancer	0.000118	0.000511	CcSEcCtD
Oxaprozin—Confusional state—Capecitabine—kidney cancer	0.000118	0.00051	CcSEcCtD
Oxaprozin—Feeling abnormal—Paclitaxel—kidney cancer	0.000118	0.000508	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000117	0.000507	CcSEcCtD
Oxaprozin—Oedema—Capecitabine—kidney cancer	0.000117	0.000506	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000117	0.000504	CcSEcCtD
Oxaprozin—Diarrhoea—Gemcitabine—kidney cancer	0.000117	0.000503	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—kidney cancer	0.000116	0.000502	CcSEcCtD
Oxaprozin—Infection—Capecitabine—kidney cancer	0.000116	0.000502	CcSEcCtD
Oxaprozin—PTGS2—C-MYB transcription factor network—GSTM1—kidney cancer	0.000116	0.00377	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	0.000116	0.00376	CbGpPWpGaD
Oxaprozin—Jaundice—Doxorubicin—kidney cancer	0.000115	0.000498	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—kidney cancer	0.000115	0.000498	CcSEcCtD
Oxaprozin—Shock—Capecitabine—kidney cancer	0.000115	0.000497	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—kidney cancer	0.000115	0.000497	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000115	0.00372	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000115	0.00372	CbGpPWpGaD
Oxaprozin—Thrombocytopenia—Capecitabine—kidney cancer	0.000115	0.000495	CcSEcCtD
Oxaprozin—Tachycardia—Capecitabine—kidney cancer	0.000114	0.000493	CcSEcCtD
Oxaprozin—Vomiting—Vincristine—kidney cancer	0.000114	0.000493	CcSEcCtD
Oxaprozin—Urticaria—Paclitaxel—kidney cancer	0.000113	0.000489	CcSEcCtD
Oxaprozin—Rash—Vincristine—kidney cancer	0.000113	0.000489	CcSEcCtD
Oxaprozin—Hyperhidrosis—Capecitabine—kidney cancer	0.000113	0.000489	CcSEcCtD
Oxaprozin—Dermatitis—Vincristine—kidney cancer	0.000113	0.000489	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—kidney cancer	0.000113	0.000487	CcSEcCtD
Oxaprozin—Body temperature increased—Paclitaxel—kidney cancer	0.000113	0.000487	CcSEcCtD
Oxaprozin—Abdominal pain—Paclitaxel—kidney cancer	0.000113	0.000487	CcSEcCtD
Oxaprozin—Headache—Vincristine—kidney cancer	0.000112	0.000486	CcSEcCtD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SOD2—kidney cancer	0.000112	0.00364	CbGpPWpGaD
Oxaprozin—Anorexia—Capecitabine—kidney cancer	0.000112	0.000482	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—kidney cancer	0.000111	0.000479	CcSEcCtD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.00011	0.00358	CbGpPWpGaD
Oxaprozin—Agranulocytosis—Doxorubicin—kidney cancer	0.00011	0.000477	CcSEcCtD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00011	0.00356	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.00011	0.00356	CbGpPWpGaD
Oxaprozin—Hypotension—Capecitabine—kidney cancer	0.000109	0.000472	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000109	0.00354	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000109	0.00352	CbGpPWpGaD
Oxaprozin—Vomiting—Gemcitabine—kidney cancer	0.000108	0.000468	CcSEcCtD
Oxaprozin—Rash—Gemcitabine—kidney cancer	0.000107	0.000464	CcSEcCtD
Oxaprozin—Dermatitis—Gemcitabine—kidney cancer	0.000107	0.000463	CcSEcCtD
Oxaprozin—PTGS2—Spinal Cord Injury—EGR1—kidney cancer	0.000107	0.00348	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000107	0.00347	CbGpPWpGaD
Oxaprozin—Haemoglobin—Doxorubicin—kidney cancer	0.000107	0.000461	CcSEcCtD
Oxaprozin—Headache—Gemcitabine—kidney cancer	0.000107	0.000461	CcSEcCtD
Oxaprozin—Nausea—Vincristine—kidney cancer	0.000107	0.000461	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—kidney cancer	0.000106	0.000459	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—kidney cancer	0.000106	0.000459	CcSEcCtD
Oxaprozin—Insomnia—Capecitabine—kidney cancer	0.000106	0.000457	CcSEcCtD
Oxaprozin—Paraesthesia—Capecitabine—kidney cancer	0.000105	0.000454	CcSEcCtD
Oxaprozin—Dyspnoea—Capecitabine—kidney cancer	0.000104	0.000451	CcSEcCtD
Oxaprozin—Dyspepsia—Capecitabine—kidney cancer	0.000103	0.000445	CcSEcCtD
Oxaprozin—Asthenia—Paclitaxel—kidney cancer	0.000102	0.000442	CcSEcCtD
Oxaprozin—Decreased appetite—Capecitabine—kidney cancer	0.000102	0.000439	CcSEcCtD
Oxaprozin—Nausea—Gemcitabine—kidney cancer	0.000101	0.000437	CcSEcCtD
Oxaprozin—Pruritus—Paclitaxel—kidney cancer	0.000101	0.000436	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.0001	0.00326	CbGpPWpGaD
Oxaprozin—Erythema multiforme—Doxorubicin—kidney cancer	0.0001	0.000434	CcSEcCtD
Oxaprozin—Constipation—Capecitabine—kidney cancer	0.0001	0.000432	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—kidney cancer	9.9e-05	0.000428	CcSEcCtD
Oxaprozin—Diarrhoea—Paclitaxel—kidney cancer	9.76e-05	0.000421	CcSEcCtD
Oxaprozin—Feeling abnormal—Capecitabine—kidney cancer	9.64e-05	0.000417	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Capecitabine—kidney cancer	9.57e-05	0.000413	CcSEcCtD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.55e-05	0.0031	CbGpPWpGaD
Oxaprozin—Arrhythmia—Doxorubicin—kidney cancer	9.48e-05	0.00041	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	9.45e-05	0.00307	CbGpPWpGaD
Oxaprozin—Dizziness—Paclitaxel—kidney cancer	9.43e-05	0.000407	CcSEcCtD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.42e-05	0.00306	CbGpPWpGaD
Oxaprozin—Alopecia—Doxorubicin—kidney cancer	9.38e-05	0.000405	CcSEcCtD
Oxaprozin—Urticaria—Capecitabine—kidney cancer	9.3e-05	0.000402	CcSEcCtD
Oxaprozin—Body temperature increased—Capecitabine—kidney cancer	9.25e-05	0.0004	CcSEcCtD
Oxaprozin—Abdominal pain—Capecitabine—kidney cancer	9.25e-05	0.0004	CcSEcCtD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—kidney cancer	9.19e-05	0.00298	CbGpPWpGaD
Oxaprozin—Flatulence—Doxorubicin—kidney cancer	9.11e-05	0.000393	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—kidney cancer	9.07e-05	0.000392	CcSEcCtD
Oxaprozin—Vomiting—Paclitaxel—kidney cancer	9.07e-05	0.000392	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—kidney cancer	9.05e-05	0.000391	CcSEcCtD
Oxaprozin—Rash—Paclitaxel—kidney cancer	8.99e-05	0.000388	CcSEcCtD
Oxaprozin—Dermatitis—Paclitaxel—kidney cancer	8.98e-05	0.000388	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—kidney cancer	8.98e-05	0.000388	CcSEcCtD
Oxaprozin—PTGS1—Biological oxidations—GSTP1—kidney cancer	8.98e-05	0.00291	CbGpPWpGaD
Oxaprozin—Methadone—ABCB1—kidney cancer	8.96e-05	0.0304	CrCbGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—kidney cancer	8.94e-05	0.0029	CbGpPWpGaD
Oxaprozin—Headache—Paclitaxel—kidney cancer	8.93e-05	0.000386	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—kidney cancer	8.71e-05	0.000376	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	8.69e-05	0.00282	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—KIT—kidney cancer	8.63e-05	0.0028	CbGpPWpGaD
Oxaprozin—Ill-defined disorder—Doxorubicin—kidney cancer	8.58e-05	0.00037	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—kidney cancer	8.54e-05	0.000369	CcSEcCtD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.5e-05	0.00276	CbGpPWpGaD
Oxaprozin—Nausea—Paclitaxel—kidney cancer	8.47e-05	0.000366	CcSEcCtD
Oxaprozin—Asthenia—Capecitabine—kidney cancer	8.4e-05	0.000363	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.35e-05	0.00271	CbGpPWpGaD
Oxaprozin—Malaise—Doxorubicin—kidney cancer	8.33e-05	0.00036	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—kidney cancer	8.3e-05	0.000359	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—kidney cancer	8.29e-05	0.000358	CcSEcCtD
Oxaprozin—Pruritus—Capecitabine—kidney cancer	8.28e-05	0.000358	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—kidney cancer	8.27e-05	0.000357	CcSEcCtD
Oxaprozin—PTGS1—Biological oxidations—GSTM1—kidney cancer	8.25e-05	0.00268	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	8.18e-05	0.00265	CbGpPWpGaD
Oxaprozin—Palpitations—Doxorubicin—kidney cancer	8.17e-05	0.000353	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—kidney cancer	8.12e-05	0.000351	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—kidney cancer	8.01e-05	0.000346	CcSEcCtD
Oxaprozin—Diarrhoea—Capecitabine—kidney cancer	8.01e-05	0.000346	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—kidney cancer	7.98e-05	0.000345	CcSEcCtD
Oxaprozin—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	7.95e-05	0.00258	CbGpPWpGaD
Oxaprozin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	7.85e-05	0.00255	CbGpPWpGaD
Oxaprozin—Anxiety—Doxorubicin—kidney cancer	7.84e-05	0.000339	CcSEcCtD
Oxaprozin—PTGS1—Biological oxidations—CYP1A1—kidney cancer	7.82e-05	0.00254	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	7.8e-05	0.00253	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	7.8e-05	0.00253	CbGpPWpGaD
Oxaprozin—Discomfort—Doxorubicin—kidney cancer	7.77e-05	0.000336	CcSEcCtD
Oxaprozin—Dizziness—Capecitabine—kidney cancer	7.74e-05	0.000334	CcSEcCtD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.74e-05	0.00251	CbGpPWpGaD
Oxaprozin—Dry mouth—Doxorubicin—kidney cancer	7.7e-05	0.000332	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	7.68e-05	0.00249	CbGpPWpGaD
Oxaprozin—Confusional state—Doxorubicin—kidney cancer	7.61e-05	0.000329	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—kidney cancer	7.54e-05	0.000326	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—kidney cancer	7.54e-05	0.000326	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	7.52e-05	0.00244	CbGpPWpGaD
Oxaprozin—Infection—Doxorubicin—kidney cancer	7.49e-05	0.000324	CcSEcCtD
Oxaprozin—Vomiting—Capecitabine—kidney cancer	7.44e-05	0.000321	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—kidney cancer	7.42e-05	0.000321	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—kidney cancer	7.39e-05	0.000319	CcSEcCtD
Oxaprozin—Rash—Capecitabine—kidney cancer	7.38e-05	0.000319	CcSEcCtD
Oxaprozin—Dermatitis—Capecitabine—kidney cancer	7.37e-05	0.000318	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—kidney cancer	7.36e-05	0.000318	CcSEcCtD
Oxaprozin—Headache—Capecitabine—kidney cancer	7.33e-05	0.000317	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	7.29e-05	0.00237	CbGpPWpGaD
Oxaprozin—Hyperhidrosis—Doxorubicin—kidney cancer	7.29e-05	0.000315	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—kidney cancer	7.19e-05	0.000311	CcSEcCtD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.12e-05	0.00231	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	7.1e-05	0.0023	CbGpPWpGaD
Oxaprozin—Hypotension—Doxorubicin—kidney cancer	7.05e-05	0.000304	CcSEcCtD
Oxaprozin—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	7e-05	0.00227	CbGpPWpGaD
Oxaprozin—Nausea—Capecitabine—kidney cancer	6.95e-05	0.0003	CcSEcCtD
Oxaprozin—PTGS1—Metabolism—ACY1—kidney cancer	6.88e-05	0.00223	CbGpPWpGaD
Oxaprozin—Insomnia—Doxorubicin—kidney cancer	6.82e-05	0.000295	CcSEcCtD
Oxaprozin—CYP2C9—Biological oxidations—GSTT1—kidney cancer	6.81e-05	0.00221	CbGpPWpGaD
Oxaprozin—Paraesthesia—Doxorubicin—kidney cancer	6.77e-05	0.000293	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—kidney cancer	6.72e-05	0.000291	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—kidney cancer	6.71e-05	0.00029	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—kidney cancer	6.64e-05	0.000287	CcSEcCtD
Oxaprozin—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	6.6e-05	0.00214	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	6.57e-05	0.00213	CbGpPWpGaD
Oxaprozin—Decreased appetite—Doxorubicin—kidney cancer	6.56e-05	0.000283	CcSEcCtD
Oxaprozin—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	6.49e-05	0.00211	CbGpPWpGaD
Oxaprozin—Constipation—Doxorubicin—kidney cancer	6.45e-05	0.000279	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	6.4e-05	0.00208	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—PTGS1—kidney cancer	6.38e-05	0.00207	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	6.35e-05	0.00206	CbGpPWpGaD
Oxaprozin—Feeling abnormal—Doxorubicin—kidney cancer	6.22e-05	0.000269	CcSEcCtD
Oxaprozin—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	6.2e-05	0.00201	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	6.2e-05	0.00201	CbGpPWpGaD
Oxaprozin—Gastrointestinal pain—Doxorubicin—kidney cancer	6.17e-05	0.000266	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—kidney cancer	5.99e-05	0.000259	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—kidney cancer	5.96e-05	0.000258	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—kidney cancer	5.96e-05	0.000258	CcSEcCtD
Oxaprozin—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	5.92e-05	0.00192	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.86e-05	0.0019	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PDHB—kidney cancer	5.85e-05	0.0019	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—POMC—kidney cancer	5.83e-05	0.00189	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.77e-05	0.00187	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.63e-05	0.00183	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CCBL1—kidney cancer	5.5e-05	0.00178	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ACY1—kidney cancer	5.46e-05	0.00177	CbGpPWpGaD
Oxaprozin—Asthenia—Doxorubicin—kidney cancer	5.41e-05	0.000234	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—kidney cancer	5.34e-05	0.000231	CcSEcCtD
Oxaprozin—PTGS2—Disease—CCBL1—kidney cancer	5.21e-05	0.00169	CbGpPWpGaD
Oxaprozin—Diarrhoea—Doxorubicin—kidney cancer	5.16e-05	0.000223	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—kidney cancer	4.99e-05	0.000215	CcSEcCtD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.97e-05	0.00161	CbGpPWpGaD
Oxaprozin—Vomiting—Doxorubicin—kidney cancer	4.8e-05	0.000207	CcSEcCtD
Oxaprozin—PTGS1—Metabolism—PPAT—kidney cancer	4.77e-05	0.00155	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GLIPR1—kidney cancer	4.77e-05	0.00155	CbGpPWpGaD
Oxaprozin—Rash—Doxorubicin—kidney cancer	4.76e-05	0.000205	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—kidney cancer	4.75e-05	0.000205	CcSEcCtD
Oxaprozin—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	4.75e-05	0.00154	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	4.73e-05	0.00153	CbGpPWpGaD
Oxaprozin—Headache—Doxorubicin—kidney cancer	4.73e-05	0.000204	CcSEcCtD
Oxaprozin—CYP2C9—Biological oxidations—GSTP1—kidney cancer	4.72e-05	0.00153	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AMER1—kidney cancer	4.71e-05	0.00153	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.71e-05	0.00153	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.66e-05	0.00151	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	4.65e-05	0.00151	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PDHB—kidney cancer	4.64e-05	0.00151	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL2—kidney cancer	4.62e-05	0.0015	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	4.51e-05	0.00146	CbGpPWpGaD
Oxaprozin—Nausea—Doxorubicin—kidney cancer	4.48e-05	0.000194	CcSEcCtD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.47e-05	0.00145	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—FH—kidney cancer	4.43e-05	0.00144	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APRT—kidney cancer	4.43e-05	0.00144	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	4.39e-05	0.00142	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CCBL1—kidney cancer	4.36e-05	0.00142	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTM1—kidney cancer	4.34e-05	0.00141	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.33e-05	0.00141	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	4.28e-05	0.00139	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPC3—kidney cancer	4.17e-05	0.00135	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	4.11e-05	0.00133	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	4.05e-05	0.00132	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CA2—kidney cancer	4.05e-05	0.00131	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALAD—kidney cancer	3.95e-05	0.00128	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GPC3—kidney cancer	3.95e-05	0.00128	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.95e-05	0.00128	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ST3GAL2—kidney cancer	3.86e-05	0.00125	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GLIPR1—kidney cancer	3.78e-05	0.00123	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPAT—kidney cancer	3.78e-05	0.00123	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALDH1A1—kidney cancer	3.77e-05	0.00122	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.74e-05	0.00121	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	3.72e-05	0.00121	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.7e-05	0.0012	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ST3GAL2—kidney cancer	3.65e-05	0.00119	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.62e-05	0.00117	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACY1—kidney cancer	3.62e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PGK1—kidney cancer	3.61e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC5A3—kidney cancer	3.61e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LDHB—kidney cancer	3.54e-05	0.00115	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.54e-05	0.00115	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—FH—kidney cancer	3.52e-05	0.00114	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APRT—kidney cancer	3.52e-05	0.00114	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.51e-05	0.00114	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.47e-05	0.00113	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.44e-05	0.00112	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PGK1—kidney cancer	3.42e-05	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SLC5A3—kidney cancer	3.42e-05	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LDHB—kidney cancer	3.36e-05	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SFRP2—kidney cancer	3.36e-05	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPC3—kidney cancer	3.31e-05	0.00107	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CA2—kidney cancer	3.22e-05	0.00104	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.21e-05	0.00104	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALAD—kidney cancer	3.14e-05	0.00102	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TCEB1—kidney cancer	3.13e-05	0.00102	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TCEB2—kidney cancer	3.13e-05	0.00102	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.08e-05	0.001	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PDHB—kidney cancer	3.07e-05	0.000997	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CA9—kidney cancer	3.07e-05	0.000997	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.07e-05	0.000995	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—POMC—kidney cancer	3.06e-05	0.000994	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.06e-05	0.000993	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.06e-05	0.000993	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.04e-05	0.000985	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3e-05	0.000974	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.99e-05	0.00097	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.97e-05	0.000963	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.96e-05	0.00096	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CCBL1—kidney cancer	2.89e-05	0.000938	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC5A3—kidney cancer	2.87e-05	0.00093	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PGK1—kidney cancer	2.87e-05	0.00093	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LDHB—kidney cancer	2.81e-05	0.000912	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.67e-05	0.000867	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.61e-05	0.000848	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CRABP1—kidney cancer	2.61e-05	0.000847	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL14—kidney cancer	2.55e-05	0.000826	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.53e-05	0.000821	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPAT—kidney cancer	2.51e-05	0.000813	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.51e-05	0.000813	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.47e-05	0.000803	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.46e-05	0.000798	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.45e-05	0.000795	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CA9—kidney cancer	2.44e-05	0.000791	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ITPR2—kidney cancer	2.43e-05	0.000788	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.41e-05	0.000781	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.38e-05	0.000773	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APRT—kidney cancer	2.33e-05	0.000756	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FH—kidney cancer	2.33e-05	0.000756	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ITPR2—kidney cancer	2.3e-05	0.000747	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.28e-05	0.000739	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.27e-05	0.000737	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.24e-05	0.000726	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ACHE—kidney cancer	2.21e-05	0.000718	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTT1—kidney cancer	2.21e-05	0.000718	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPC3—kidney cancer	2.19e-05	0.000711	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CA2—kidney cancer	2.13e-05	0.000691	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SCARB1—kidney cancer	2.1e-05	0.00068	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.09e-05	0.000677	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALAD—kidney cancer	2.08e-05	0.000674	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CRABP1—kidney cancer	2.07e-05	0.000673	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PSMD7—kidney cancer	2.03e-05	0.00066	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.03e-05	0.000658	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.02e-05	0.000655	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.98e-05	0.000643	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BCHE—kidney cancer	1.93e-05	0.000626	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PSMD7—kidney cancer	1.93e-05	0.000626	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ITPR2—kidney cancer	1.93e-05	0.000625	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC5A5—kidney cancer	1.91e-05	0.000618	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PGK1—kidney cancer	1.9e-05	0.000616	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.9e-05	0.000616	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LDHB—kidney cancer	1.86e-05	0.000604	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC2A1—kidney cancer	1.84e-05	0.000597	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.79e-05	0.000579	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.78e-05	0.000576	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTT1—kidney cancer	1.76e-05	0.00057	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ACHE—kidney cancer	1.76e-05	0.00057	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SLC2A1—kidney cancer	1.74e-05	0.000566	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JUNB—kidney cancer	1.73e-05	0.000562	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SCARB1—kidney cancer	1.66e-05	0.00054	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTGS1—kidney cancer	1.65e-05	0.000534	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PSMD7—kidney cancer	1.62e-05	0.000524	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CA9—kidney cancer	1.61e-05	0.000524	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.58e-05	0.000512	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.56e-05	0.000505	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—kidney cancer	1.53e-05	0.000498	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BCHE—kidney cancer	1.53e-05	0.000497	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC5A5—kidney cancer	1.51e-05	0.000491	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC2A1—kidney cancer	1.46e-05	0.000474	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCB1—kidney cancer	1.45e-05	0.000471	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—kidney cancer	1.41e-05	0.000458	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN2B—kidney cancer	1.41e-05	0.000457	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CRABP1—kidney cancer	1.37e-05	0.000445	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1A1—kidney cancer	1.34e-05	0.000434	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ITPR2—kidney cancer	1.28e-05	0.000414	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.24e-05	0.000401	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—kidney cancer	1.22e-05	0.000395	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.18e-05	0.000382	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACHE—kidney cancer	1.16e-05	0.000378	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTT1—kidney cancer	1.16e-05	0.000378	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCB1—kidney cancer	1.15e-05	0.000374	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HIF1A—kidney cancer	1.13e-05	0.000366	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TSC2—kidney cancer	1.12e-05	0.000365	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—kidney cancer	1.12e-05	0.000363	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SCARB1—kidney cancer	1.1e-05	0.000357	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.1e-05	0.000356	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS1—kidney cancer	1.09e-05	0.000354	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PSMD7—kidney cancer	1.07e-05	0.000347	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1A1—kidney cancer	1.06e-05	0.000344	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BCHE—kidney cancer	1.01e-05	0.000329	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC5A5—kidney cancer	1e-05	0.000325	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—POMC—kidney cancer	9.97e-06	0.000323	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KIT—kidney cancer	9.93e-06	0.000322	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—kidney cancer	9.93e-06	0.000322	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC2A1—kidney cancer	9.67e-06	0.000314	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.39e-06	0.000304	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BRAF—kidney cancer	9.33e-06	0.000303	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.72e-06	0.000283	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.19e-06	0.000266	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—kidney cancer	8.07e-06	0.000262	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—kidney cancer	7.95e-06	0.000258	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—POMC—kidney cancer	7.91e-06	0.000257	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RAF1—kidney cancer	7.79e-06	0.000253	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB2—kidney cancer	7.71e-06	0.00025	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCB1—kidney cancer	7.64e-06	0.000248	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTOR—kidney cancer	7.61e-06	0.000247	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD4—kidney cancer	7.59e-06	0.000246	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—kidney cancer	7.41e-06	0.000241	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1B—kidney cancer	7.14e-06	0.000232	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.03e-06	0.000228	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—kidney cancer	6.93e-06	0.000225	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CTNNB1—kidney cancer	6.74e-06	0.000219	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—kidney cancer	6.57e-06	0.000213	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.77e-06	0.000187	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK3—kidney cancer	5.62e-06	0.000182	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—kidney cancer	5.51e-06	0.000179	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—kidney cancer	5.46e-06	0.000177	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK1—kidney cancer	5.34e-06	0.000173	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—POMC—kidney cancer	5.24e-06	0.00017	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—kidney cancer	5.05e-06	0.000164	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—kidney cancer	4.89e-06	0.000159	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—kidney cancer	4.64e-06	0.00015	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—kidney cancer	4.18e-06	0.000136	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—kidney cancer	3.88e-06	0.000126	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—kidney cancer	3.65e-06	0.000118	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.57e-06	8.34e-05	CbGpPWpGaD
